Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.97 Million CAD | 85.39% |
| 2022 | -20.34 Million CAD | -667.33% |
| 2021 | -2.65 Million CAD | -1794.3% |
| 2020 | -139.98 Thousand CAD | -3971.79% |
| 2019 | -3438.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.54 Million CAD | -1062.09% |
| 2024 Q1 | -218.74 Thousand CAD | 60.43% |
| 2023 Q2 | -961.44 Thousand CAD | 9.32% |
| 2023 Q4 | -552.87 Thousand CAD | -38.09% |
| 2023 FY | -2.97 Million CAD | 85.39% |
| 2023 Q3 | -400.38 Thousand CAD | 58.36% |
| 2023 Q1 | -1.06 Million CAD | 94.02% |
| 2022 Q1 | -821.61 Thousand CAD | 65.64% |
| 2022 FY | -20.34 Million CAD | -667.33% |
| 2022 Q4 | -17.71 Million CAD | -1670.57% |
| 2022 Q3 | -1 Million CAD | -23.77% |
| 2022 Q2 | -808.59 Thousand CAD | 1.58% |
| 2021 Q2 | -92.37 Thousand CAD | -32.6% |
| 2021 Q1 | -69.66 Thousand CAD | 49.59% |
| 2021 FY | -2.65 Million CAD | -1794.3% |
| 2021 Q4 | -2.39 Million CAD | -1962.38% |
| 2021 Q3 | -115.94 Thousand CAD | -25.51% |
| 2020 FY | -139.98 Thousand CAD | -3971.79% |
| 2020 Q3 | -47.93 Thousand CAD | 0.0% |
| 2020 Q4 | -138.19 Thousand CAD | -188.3% |
| 2019 FY | -3438.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AI/ML Innovations Inc. | -3.28 Million CAD | 9.497% |
| Diagnamed Holdings Corp. | -1.27 Million CAD | -132.634% |
| nDatalyze Corp. | -155.6 Thousand CAD | -1810.601% |
| Treatment.Com International Inc. | -3.72 Million CAD | 20.134% |
| Unidoc Health Corp. | -2.25 Million CAD | -31.554% |